“Ageing, redox metabolism and lung cancer: Could it be that lung tumours in the elderly never grow old?”

A light lunch will be served in the foyer following the presentation.

After earning a degree in Pharmacology from the University of Gothenburg and completing a Ph.D. in Medical Sciences at the Sahlgrenska Academy in 2014, Associate Professor Volkan Sayin pursued postdoctoral research at NYU Langone Medical Center in New York. his work focused on elucidating the role of antioxidants and redox signalling pathways in lung cancer progression leading up to multiple phase I/II precision trials.

Currently, Volkan is an Associate Professor at the University of Gothenburg. Since 2019, his laboratory based at the Sahlgrenska Center for Cancer Research has been dedicated to studying cancer metabolism, ageing, and redox biology. Their research aims to uncover the fundamental mechanisms driving tumour initiation, progression, and metastasis—the process by which cancer cells spread from a primary tumour to distant organs. To achieve this, they have developed a patient-derived precision medicine platform that integrates surgery, oncology, pathology, and preclinical molecular medicine. By leveraging advanced animal models, precise genome editing technologies, 13C metabolomic flux pipeline and well-characterised clinical cohorts, along with a global network of academic, clinical, and industrial collaborators, they strive to unravel the complexities of cancer. Ultimately, their goal is to translate scientific discoveries into therapeutic innovations that advance the field of precision oncology.